Cargando…

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

OBJECTIVES: Numerous case reports have referred to new onset or flare of SLE after SARS-CoV-2 messenger RNA (mRNA) vaccines. Several observational studies showed that the short-term flare rate of SLE after SARS-CoV-2 vaccination is low. However, well-controlled clinical surveys are unavailable and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Tsuneyasu, Tsuji, Hideaki, Onishi, Akira, Takase, Yudai, Shirakashi, Mirei, Onizawa, Hideo, Hiwa, Ryosuke, Kitagori, Koji, Akizuki, Shuji, Nakashima, Ran, Tanaka, Masao, Yoshifuji, Hajime, Morinobu, Akio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Epidemiology and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378947/ https://www.ncbi.nlm.nih.gov/pubmed/35961691 http://dx.doi.org/10.1136/lupus-2022-000727

Ejemplares similares

The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection
por: Mukoyama, Hiroki, et al.
Publicado: (2021)

Risk factors for the recurrence of relapsing polychondritis
por: Yoshida, Tsuneyasu, et al.
Publicado: (2022)

Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation
por: Tabuchi, Yuya, et al.
Publicado: (2022)

Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study
por: Nakayama, Yoichi, et al.
Publicado: (2023)

Fatostatin ameliorates inflammation without affecting cell viability
por: Ma, Shuhe, et al.
Publicado: (2022)

ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis
por: Matsuo, Takashi, et al.
Publicado: (2022)

Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model
por: Gon, Yoshie, et al.
Publicado: (2023)

A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus
por: Kitagori, Koji, et al.
Publicado: (2023)

Increased Ratio of CD14(++)CD80(+) Cells/CD14(++)CD163(+) Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients
por: Ma, Shuhe, et al.
Publicado: (2021)

A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation
por: Law, Sze-Ming, et al.
Publicado: (2022)

Large vessel vasculopathy in a patient with systemic lupus erythematosus: a case report
por: Waki, Daisuke, et al.
Publicado: (2019)

Coping with systemic lupus erythematosus in patients’ words
por: Cornet, Alain, et al.
Publicado: (2022)

CD8(+) Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis
por: Watanabe, Ryu, et al.
Publicado: (2023)

Clinical and histopathological features of myositis in systemic lupus erythematosus
por: Tiniakou, Eleni, et al.
Publicado: (2022)

Causes and outcome of hospitalisations in Tunisian patients with systemic lupus erythematosus
por: Jallouli, M, et al.
Publicado: (2014)

Off-label use of rituximab for systemic lupus erythematosus in Europe
por: Rydén-Aulin, Monica, et al.
Publicado: (2016)

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020)

Development of a systemic lupus erythematosus cardiovascular risk equation
por: Petri, Michelle A, et al.
Publicado: (2019)

Association of patient copayment and medication adherence in systemic lupus erythematosus
por: Lomanto Silva, Raisa, et al.
Publicado: (2023)

Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients
por: Kiso, Kaori, et al.
Publicado: (2017)

Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus
por: Carli, L, et al.
Publicado: (2016)

Complement levels and risk of organ involvement in patients with systemic lupus erythematosus
por: Gandino, Ignacio Javier, et al.
Publicado: (2017)

Serum uric acid is associated with damage in patients with systemic lupus erythematosus
por: Elera-Fitzcarrald, Claudia, et al.
Publicado: (2020)

Living with systemic lupus erythematosus in 2020: a European patient survey
por: Cornet, Alain, et al.
Publicado: (2021)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000s
por: Albrecht, Katinka, et al.
Publicado: (2014)

Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival
por: Kazzaz, Nayef M, et al.
Publicado: (2015)

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
por: Thanou, Aikaterini, et al.
Publicado: (2019)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study
por: Schlencker, Aurelien, et al.
Publicado: (2022)

Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study
por: Vina, Ernest R, et al.
Publicado: (2015)

Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus
por: Utset, Tammy O, et al.
Publicado: (2015)

Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus
por: Kheir, Joseph M, et al.
Publicado: (2018)

Illness representations of systemic lupus erythematosus and systemic sclerosis: a comparison of patients, their rheumatologists and their general practitioners
por: Arat, Seher, et al.
Publicado: (2017)

Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2020)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

Use of a screening questionnaire for systemic lupus erythematosus among pregnant women in a Mexican population
por: Lucero-Morales, Luis, et al.
Publicado: (2021)

Predictors of refractory risk in systemic lupus erythematosus-related thrombocytopenia: a dual-centre retrospective study
por: Su, Kaisheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qvjkqp2nr34pk0raikhfk6qiin